Found 6 matching trials
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection PHASE2 This study will investigate if Toripalimab (A PD-1 Inhibitor) will improve ...
Show More Status
Active Not Recruiting
Location
Zhongshan Hospital,Fudan University
Learn More & Join Trial
A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma PHASE3 This is one phase III, randomized, open-label study in comparison of JS001 ...
Show More Location
Hefei Binhu Hospital
Learn More & Join Trial
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma PHASE2 Small cell esophageal carcinoma (SCCE) is a kind of malignant tumor with po...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer PHASE2 For locally advanced gastric cancer (cT3-4aN+M0), neoadjuvant chemotherapy ...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC PHASE1 The purpose of this study is to preliminarily evaluate anti-tumor activity ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial PHASE2 For locally advanced esophagogastric junction and gastric cancer (cT3-4aNxM...
Show More Location
Fujian Provincial Hospital
Learn More & Join Trial